Announced Fri, 26 Jun · 12:25 IST
Trading window closed from July 1 ahead of Q1 FY27 results
Compliance View source PDF
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹194.68
prior close
₹204.41
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0-0.2+10.2+15.8+13.4+11.2+9.0+4.8+17.6———
Up moveDown movePending
AI summary
Bafna Pharmaceuticals has closed its trading window from July 1, 2026 until 48 hours after declaring unaudited financial results for the quarter ending June 30, 2026. This is a routine SEBI insider trading compliance step taken before quarterly results. Designated persons and their immediate relatives cannot trade in the company shares during this period.
Likely market impact
Routine compliance filing. No material impact on shareholders. Signals upcoming Q1 FY27 results announcement.